Security key
87164F105
Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (SNDX)
CUSIP: 87164F105
Q1 2024 13F Holders as of 31 Mar 2024
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 90,291,619
- Total 13F value
- $2,148,803,982
- Share change
- +1,753,727
- Put/Call ratio
- 75%
- SEC-reported price per share
- $23.80
- Number of holders
- 188
- Value change
- +$45,990,918
- Number of buys
- 113
- Number of sells
- 69
- Shares outstanding
- 86,328,130
Holder snapshot
7 signals
Show 1 more signal
Security identity
1 source field
Report period
Q1 2024
Institutions
188
Top holders
10
SNDX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2024
Previous quarter: Q4 2023
Syndax Pharmaceuticals Inc SEC filings
Syndax Pharmaceuticals Inc company facts
Broader feeds
Reporting periods
Holder history for CUSIP 87164F105
Recent filing periods:
Ownership snapshot
Top reported holders of SNDX - Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
WELLINGTON MANAGEMENT GRO...
Disclosed value leader
WELLINGTON MANAGEMENT GRO...
Comparable rows
15/15
Latest evidence
31 Dec 2023
13F
Lead comparable stake: 8.8%
Showing 1-6 of 15 holder rows.
Quick read
WELLINGTON MANAGEMENT GROUP LLP leads the comparable SEC ownership view at 8.8%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
WELLINGTON MANAGEMENT GROUP LLP
8.8%
BlackRock Finance, Inc.
8.1%
Kynam Capital Management, LP
6.6%
STATE STREET CORP
5.8%
VANGUARD GROUP INC
5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP |
13F
Company
|
8.8%
|
$163,916,627
7,585,221 shares
|
— | 31 Dec 2023 |
| BlackRock Finance, Inc. |
13F
Company
|
8.1%
|
$151,605,991
7,015,548 shares
|
— | 31 Dec 2023 |
| Kynam Capital Management, LP |
13F
Company
|
6.6%
|
$122,312,600
5,660,000 shares
|
— | 31 Dec 2023 |
| STATE STREET CORP |
13F
Company
|
5.8%
|
$108,400,601
5,016,224 shares
|
— | 31 Dec 2023 |
| VANGUARD GROUP INC |
13F
Company
|
5%
|
$93,686,978
4,335,353 shares
|
— | 31 Dec 2023 |
| Avoro Capital Advisors LLC |
13F
Company
|
4.9%
|
$91,242,217
4,222,222 shares
|
— | 31 Dec 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
188
Shares
90,291,619
Rows available
188
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2024 vs Q4 2023 Across Filers
Q4 2023 holders
176
Q1 2024 holders
188
Holder diff
12
| Investor | Q4 2023 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q4 2023 value | Q1 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend